FLUMAZENIL and COMA

Overview

COMA is the #4 most commonly reported adverse reaction for FLUMAZENIL, manufactured by Baxter Healthcare Corporation. There are 69 FDA adverse event reports linking FLUMAZENIL to COMA. This represents approximately 3.2% of all 2,155 adverse event reports for this drug.

Patients taking FLUMAZENIL who experience coma should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COMA is moderately reported among FLUMAZENIL users, representing a notable but not dominant share of adverse events.

Other Side Effects of FLUMAZENIL

In addition to coma, the following adverse reactions have been reported for FLUMAZENIL:

• INTENTIONAL OVERDOSE — 102 reports
• DRUG INEFFECTIVE — 88 reports
• TOXICITY TO VARIOUS AGENTS — 88 reports
• OFF LABEL USE — 69 reports
• INTENTIONAL PRODUCT MISUSE — 61 reports
• DRUG DEPENDENCE — 57 reports
• PRODUCT USE ISSUE — 55 reports
• HYPOTENSION — 54 reports
• DEPRESSED LEVEL OF CONSCIOUSNESS — 52 reports
• SEIZURE — 47 reports

Other Drugs Associated with COMA

The following drugs have also been linked to coma in FDA adverse event reports:

Does FLUMAZENIL cause COMA?

COMA has been reported as an adverse event in 69 FDA reports for FLUMAZENIL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COMA with FLUMAZENIL?

COMA accounts for approximately 3.2% of all adverse event reports for FLUMAZENIL, making it a notable side effect.

What should I do if I experience COMA while taking FLUMAZENIL?

If you experience coma while taking FLUMAZENIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages